Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C10H10N4O3 |
| Molecular Weight | 234.2114 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
OC[C@H]1O[C@H](C=C1)N2C=NC3=C2N=CNC3=O
InChI
InChIKey=TYQPBHYPIRLWKU-NKWVEPMBSA-N
InChI=1S/C10H10N4O3/c15-3-6-1-2-7(17-6)14-5-13-8-9(14)11-4-12-10(8)16/h1-2,4-7,15H,3H2,(H,11,12,16)/t6-,7+/m0/s1
| Molecular Formula | C10H10N4O3 |
| Molecular Weight | 234.2114 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Comparative activity of 2',3'-saturated and unsaturated pyrimidine and purine nucleosides against human immunodeficiency virus type 1 in peripheral blood mononuclear cells. | 1988 Oct 1 |
|
| cycloSal-Pronucleotides of 2',3'-dideoxyadenosine and 2', 3'-dideoxy-2',3'-didehydroadenosine: synthesis and antiviral evaluation of a highly efficient nucleotide delivery system. | 1999 May 6 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 03:27:57 GMT 2023
by
admin
on
Sat Dec 16 03:27:57 GMT 2023
|
| Record UNII |
849Y7EQ734
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DTXSID80195544
Created by
admin on Sat Dec 16 03:27:57 GMT 2023 , Edited by admin on Sat Dec 16 03:27:57 GMT 2023
|
PRIMARY | |||
|
135418295
Created by
admin on Sat Dec 16 03:27:57 GMT 2023 , Edited by admin on Sat Dec 16 03:27:57 GMT 2023
|
PRIMARY | |||
|
849Y7EQ734
Created by
admin on Sat Dec 16 03:27:57 GMT 2023 , Edited by admin on Sat Dec 16 03:27:57 GMT 2023
|
PRIMARY | |||
|
42867-68-5
Created by
admin on Sat Dec 16 03:27:57 GMT 2023 , Edited by admin on Sat Dec 16 03:27:57 GMT 2023
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
PARENT -> IMPURITY |
In the chromatogram obtained with solution (2), the following peaks are eluted at the following relative retention with reference to didanosine (retention time about 13-15 min): impurity F about 0.8.
The area of any individual peak corresponding to impurity F is not greater than 0.2 times the area of the principal peak obtained with solution (4) (0.2%).
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
